NAFDAC Orders Nationwide Recall of MR.7 Super 700000 Capsules Over Hidden Viagra Ingredients

The National Agency for Food and Drug Administration and Control (NAFDAC) has directed the immediate recall of all batches of MR.7 Super 700000 capsules following the discovery of undeclared pharmaceutical ingredients in the product.

In a public alert issued on Monday, the agency stated that the recall was initiated based on findings from the U.S. Food and Drug Administration (FDA), which detected the presence of sildenafil and tadalafil—potent prescription drugs used to treat erectile dysfunction—within the supplement.

NAFDAC emphasized that these substances, known as phosphodiesterase-5 (PDE-5) inhibitors, were not listed on the product label. Consequently, MR.7 Super 700000 capsules are classified as unapproved drugs, as their safety and efficacy have not been properly vetted.

The product, manufactured by StuffbyNainax LLC and marketed as a dietary supplement for male enhancement, should not contain any active pharmaceutical ingredients, the regulator noted.

Consumers and retailers have been urged to discontinue use or sales immediately and to return any stock to the nearest NAFDAC office.

The agency warned that consuming undisclosed sildenafil or tadalafil poses severe health risks, particularly for individuals on nitrate-based medications for heart conditions, such as nitroglycerin. Such interactions can trigger a dangerous drop in blood pressure and may prove fatal. Those with diabetes, hypertension, high cholesterol, or heart disease are especially vulnerable.

NAFDAC further called on healthcare providers and the public to report any suspicions of counterfeit or substandard drugs through its official reporting channels.

This latest recall aligns with recent regulatory actions by NAFDAC against unsafe and falsified medical products, including counterfeit batches of Avastin (Bevacizumab) 400 mg vials used in cancer therapy.

The agency reaffirmed its dedication to protecting public health through ongoing surveillance of the quality, safety, and effectiveness of medicines available in Nigeria.

About The Author

Dele Fashomi

Dele Fashomi, seasoned journalist and communication teacher, is a holder of Master of Arts degree in Communication and Language Arts from the University of Ibadan in 1992/93.

Earlier, he had bagged a Bachelor degree from the same university in 1984, after which he proceeded to the Nigerian Institute of Journalism, Lagos, in 1990, for a postgraduate diploma in Journalism.

He had done many courses in communication, including the EU-BBC Editing Course in 2002.

Mr. Fashomi combines effectively the practice, research and teaching of communication. And to date, he has published two academic works in communication: Issues in Communication Technology and Policy (2010) and Economic and Social Issues in Advertising and PR (2013).

He had his first break in the Nigerian media in Concord Newspapers in 1990 and today, he has over two and half decades experience earned in several newspapers.

He has been part of many start-ups, such as The Republic (1987), The Comet (1999), The Anchor 2001 – 2002; Sun Newspapers (2003); Westerner newsmagazine (2005 – 2010) as Editor; National Life (2011) as Sunday Editor, and Newswatch Newspapers (2012- 2016) as Daily Editor.

Dele Fashomi is now the Publisher/Editor-in-Chief of Newstide247.com newspaper online, which he started in July 2015. He is also into biography writing, with many books in his trail, some of which he wrote alone and one he co- authored with his mentor, Mr Dare Babarinsa, entitled:  Olabiyi Durojaiye – DARE TO BE DiFFERENT. He also guided and collaborated with Pa Olatunji Odusanya in writing his autobiography – AGAINST ALL ODDS. There are many other books in the works under his pen.

See author's posts